OPK touts a $900 million potential for its Rayaldee drug that is unlikely to be achieved. The recent increase in revenue is almost entirely attributed to COVID-19 testing. Once a vaccine rollout is ...

OPKO Health Inc.’s OPK BioReference Laboratories, Inc. recently announced that it has started accepting specimens for a new multiplex COVID-19 and influenza test, which can be utilized by healthcare ...

We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. OPKO Health, Inc. is one of them. OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company with ...

Each year, there are around 200,000 distinct insider transactions reported to SEC via Form 4 filings. While the term “insider trading” sounds nefarious, there are just a handful of cases deemed ...

OPKO Health Inc.’s OPK company — BioReference Laboratories — recently made an announcement regarding its COVID-19 testing preparedness in the face of the Omicron Variant. In fact, BioReference’s PCR ...

BioReference Laboratories, an OPKO Health (NASDAQ:OPK) has announced a COVID-19 testing agreement for players and staff, stadium employees and league staff for the 2021 Major League Baseball season.

In previous columns, I was very bearish on Co-Diagnostics (NASDAQ:CODX) and XpressSpa (NASDAQ:XSPA). Both stocks are plays on testing for the novel coronavirus. However, Opko Health (NASDAQ:OPK) stock ...